Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Clinical trial NCT06842173 · RECRUITING

Trial details

NCT number: NCT06842173
Sponsor: Butantan Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Avian Influenza A Virus

Start date: 2025-09-10
Primary completion: 2027-08-10
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.